MB
MPM BioImpact’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.6M | Hold |
7,648,268
| – | – | 9.98% | 1 |
|
|
2025
Q1 | $57.9M | Hold |
7,648,268
| – | – | 9.95% | 1 |
|
|
2024
Q4 | $93.2M | Hold |
7,648,268
| – | – | 13.23% | 1 |
|
|
2024
Q3 | $128M | Hold |
7,648,268
| – | – | 19.21% | 1 |
|
|
2024
Q2 | $133M | Hold |
7,648,268
| – | – | 20.73% | 1 |
|
|
2024
Q1 | $130M | Hold |
7,648,268
| – | – | 20.95% | 1 |
|
|
2023
Q4 | $77.9M | Hold |
7,648,268
| – | – | 18.23% | 1 |
|
|
2023
Q3 | $69.2M | Hold |
7,648,268
| – | – | 18.48% | 1 |
|
|
2023
Q2 | $82.3M | Hold |
7,648,268
| – | – | 16.57% | 1 |
|
|
2023
Q1 | $78.2M | Hold |
7,648,268
| – | – | 20.33% | 1 |
|
|
2022
Q4 | $80.7M | Hold |
7,648,268
| – | – | 20.93% | 1 |
|
|
2022
Q3 | $98.1M | Hold |
7,648,268
| – | – | 23.22% | 1 |
|
|
2022
Q2 | $98.1M | Hold |
7,648,268
| – | – | 27.24% | 1 |
|
|
2022
Q1 | $80.1M | Hold |
7,648,268
| – | – | 21.49% | 1 |
|
|
2021
Q4 | $118M | Hold |
7,648,268
| – | – | 21.51% | 1 |
|
|
2021
Q3 | $173M | Sell |
7,648,268
-265,619
| -3% | -$6M | 26.78% | 1 |
|
|
2021
Q2 | $204M | Hold |
7,913,887
| – | – | 33.48% | 1 |
|
|
2021
Q1 | $330M | Buy |
+7,913,887
| New | +$330M | 41.43% | 1 |
|